October 24, 2026 — RNews

#vaso-occlusion — Saturday, October 24, 2026 (1 items)

hot top new

← prev day next day →

30

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial. (linkinghub.elsevier.com)

Andemariam B … Abboud MR The Lancet 2026-10-24

#clinical trial #sickle cell disease #hemolytic anemia #pharmacotherapy #vaso-occlusion